MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • INFLUENCES OF GENDER, DEPRESSION AND DISEASE SEVERITY ON MoCA SUBSCORES IN PARKSINON’S DISEASE

    P. Surathi, M. Mirian, K. Sundvick, S. Cresswell, M. McKeown (Vancouver, BC, Canada)

  • Information Content of Spoken Language in Parkinson’s Disease Without Dementia

    A. Roberts, D. Post, S. Gutierrez (Evanston, IL, USA)

  • Information transfer between subthalamic area and forearm muscles during tonic muscle activity in Parkinson’s patients

    I. Weber, E. Florin, M. von Papen, L. Timmermann (Marburg, Germany)

  • Infusion Rate Dependent Acute Neuropathic Pain with Duopa™ in a Patient with Parkinson’s disease and Pre-Existing Neuropathy

    A. Shukla, R. Govindarajan, I. Asher (Columbia, MO, USA)

  • Inhaling xenon ameliorates L-DOPA-induced dyskinesia in Parkinson disease through normalizing maladaptive corticostriatal plasticity

    E. Bezard, J. Bauffreton, Q. Li, G. Porras, W.K. Ko, E. Pioli, M. Cazalon, S. Morin, G. Farjot, J. Pype, B. Bessiere (Bordeaux, France)

  • Inhibiting sphingosine-1-phosphate lyase as a possible therapy in Huntington’s disease

    E. Furr Stimming, J.F. Manchon, A. Tsvetkov (Houston, TX, USA)

  • Inhibition of long term memory and induction of biochemical deficits in rats following protofibrillar Aβ 1-42 injection

    B. Nehru, S. Sharma (Chandigarh, India)

  • Inhibition of mitochondrial complex I synthesis by chloramphenicol mitigates dopaminergic neuronal cell loss in PQ-induced parkinsonism

    S.J. Kim, J. Han, Y. Jang, J. Kim, M.J. Lee, I. Ryu, X. Ju, M.J. Ryu, W. Chung, J.Y. Heo (Daejeon, Republic of Korea)

  • Injection guidance use in the management of cervical dystonia with botulinum toxin

    D. Charles, T.M. Chung, C. Colosimo, V. Misra, P. Maisonobe, S. Om (Nashville, TN, USA)

  • Innovative recruitment strategies accelerate enrollment of genetic mutation carriers in the Parkinson’s Progression Markers Initiative (PPMI)

    V. Arnedo, S. Lasch, T. Foroud, L. Heathers, J. Martorelli, C. Halter, N. Ryerson, J. Verbrugge, L. Cook, K. Marek (New York, NY, USA)

  • « Previous Page
  • 1
  • …
  • 77
  • 78
  • 79
  • 80
  • 81
  • …
  • 155
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley